US PRE-MARKET MOVERS: META, NVDA, PANW, CDNS, MRNA, VRSK, GPN, DINO, APLD, NYT, GLBE, WING, MCW, PLTR
Newsquawk Staff ·
ES +0.4%, NQ +0.6%, RTY +0.1%.
- META -0.3%, NVDA +2.2%: META to buy millions of NVDA Vera Rubin chips.
- PANW -6.7%: Profit guidance missed.
- CDNS +6.8%: Q4 results beat w/ firm FY profit outlook.
- MRNA +8.2%: FDA accepted its application to review mRNA-1010.
- VRSK +12.1%: Adj. EPS & rev. beat.
- GPN +11.0%: Q metrics beat w/ outlook strong; to purchase $2.5B of shares.
- DINO -8.4%: Adj. EPS & rev. beat.
- APLD -8.1%: NVDA dissolved its stake in the Co.
- NYT +3%: Berkshire Hathaway initiates a stake.
- GLBE +25.6%: Q metrics & guidance topped.
- WING +14.0%: Profit beat.
- MCW +16.6%: To be taken private by Leonard Green & Partners for $7.00/shr.
- PLTR +3.0%: Upgraded at Mizuho to 'Outperform' from 'Neutral'
- US EQUITY OPEN: Indices rangebound ahead of FOMC and major earnings
- Verisk (VRSK) integrates insurance intelligence with Amazon (AMZN) and Microsoft (MSFT) AI platforms
- US PRE-MARKET MOVERS: SKHY, NXPI, ENPH, APH, GOOGL, HOOD, PPG, VRT, GEV, GEHC, BSX, ETSY, WEN, V
- US Broker Moves: ENPH and DYN downgraded at Oppenheimer; FFIV downgraded at Piper Sandler
- EUROPEAN OPEN: SKHY surges after Q3 profits; EQNR NO lifts FY production view; UBSG SW Q3 net income miss; DBK GY posts third straight record profit; MBG GY Q3 revenue & earnings fall; ULVR LN raises FY volume growth view; GSK LN Q3 profit & revenue beat
Related headlines
- Biogen Inc. (BIIB) Q3 2026 (USD): Adj. EPS 2.62 (exp. 1.98), Revenue 2.8bln (exp. 2.63bln). Raises lower end of FY26 diluted EPS guidance to USD 12.20-13.00 (exp. 12.23, prev. 12.00-13.00)5 hours ago
- Newsquawk US Daily Equity Opening News - SKHY surges after op profit beat; NXPI & STX down after results2 hours ago
- Senior US Treasury trade official Eric Ettorre will leave to join Netflix (NFLX), reports Axios2 hours ago
- T-Mobile (TMUS) CEO to step down from the board2 hours ago
- GE Healthcare Technologies Inc. (GEHC) Q3 (USD): Adj. EPS 1.34 (exp. 1.20), Revenue 5.5bln (exp. 5.35bln), Adj. EBIT 913mln (exp. 838.8mln)4 hours ago
- [MARKET ANALYSIS] A busy morning for EU banking names, with tech stocks supported by upbeat SK Hynix earnings5 hours ago
- Daily US Conference Calendar - 28th October 2026: JNJ, BA, CAT3 hours ago
- Phillips 66 (PSX) Q3 2026 (USD): Adj. EPS 14.08 (exp. 11.73)4 hours ago
- US Midterms (6 days out): Florida flips to a Republican early-vote lead and Kansas narrows further; Crystal Ball shifts House and Senate races towards Democrats2 hours ago
- South Korea fines Google (GOOGL) and Apple (AAPL) KRW 63.7bln for requiring in-app payments, sources say7 hours ago
- UK Budget, 28th October 2026: An uneventful budget expected, but the reaction risks are skewed negative3 hours ago
- Eli Lilly’s (LLY) retatrutide delivered greater A1C reduction and more than double the weight loss of Novo Nordisk’s (NOVOB DC) Ozempic at its highest approved dose in head-to-head trial4 hours ago
- Canada's Competition Bureau says proposed arrangements between Air Canada and United Airlines (UAL) would lead to higher prices, with the Transport Minister set to review the findings of its investigation46 min ago
- JPMorgan Chase (JPM) reportedly faces an additional GBP 100-150mln tax bill following the UK government's decision to double the corporation tax surcharge on banks, potentially jeopardising plans for its new London headquarters, Sky News reports48 min ago
- Amphenol (APH) Q3 2026 (USD): Adj. EPS 0.80 (exp. 0.73), Sales 10.2bln (exp. 9.49bln)3 hours ago